Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13f23c0ba8ee6f80e89543d0edf02b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4a95c7328e9c63a07ce2de92c34d8f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1deb609288d33b51b741b4c4703f2c2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
filingDate |
2003-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5e109a6521e9943ca051eedae14085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79b0d6939c6090402f51f6f385d2cd9 |
publicationDate |
2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004038404-A2 |
titleOfInvention |
Method for optimizing therapeutic efficacy of nemorubicin |
abstract |
The present invention relates to products and methods for characterizing cancer patients in order to predict therapeutic benefit with a drug metabolized by CYP3A, especially nemorubicin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008519584-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006052976-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006052976-A3 |
priorityDate |
2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |